期刊文献+

药物性肝炎47例临床分析 被引量:6

Clinical analysis of drug-induced liver disease
在线阅读 下载PDF
导出
摘要 目的探讨47例药物性肝炎患者的病因和临床特点,以提高对该病的认识。方法采用回顾性分析法对47例药物性肝炎住院患者的用药史、临床表现、肝功能检查、病原学标志以及治疗转归做出综合分析。结果引起肝病的相关药物中抗生素类占23.4%(11/47),中药及解热镇痛药各占21.3%(10/47)、抗肿瘤药占10.6%(5/47)、抗结核药及H2受体拮抗剂各占8.5%(4/47)、其他占6.4%(3/47)。临床表现为急性肝炎44例,慢性肝炎3例(主要有乏力、纳差、黄疸和转氨酶升高)。经停药并给予保肝治疗,45例预后良好,1例发展至肝硬化,1例因重症肝炎而死亡。结论应重视药物性肝炎的预防、诊断和治疗。 Objective To expand the knowledge of drug-induced liver disease by analyzing the etiology and clinical features of 47 patients with drug-induced hver disease. Methods 47 cases with drug-induced liver damage admitted to our hospital from 1995 to 2004. They were reviewed with respect to their drug history, clinical symptom and signs, liver function test, serum viral markers and therapeutic effect. Results The drugs involved were antibiotics in 23.4%, analgesics and herbal medicine in 21.3 %, respectively, anti-tumor agents in 10.6%, anti-tuberculous agents and H2 -receptor antagonist in 8.5 % , respectively. There were 44 patients with acute and 3 with chronic drug-induced liver disease. The dominating clinical manifestations were fatigue, loss of appetite, jaundice and elevated transaminase.45 patients (93.6%) were recovered with good prognosis. Conclusion Prevention and diagnosis of drug-induced liver disease is of importance in clinical practice.
出处 《实用肝脏病杂志》 CAS 2005年第6期334-336,共3页 Journal of Practical Hepatology
关键词 药物性肝炎 临床特点 Drug-induced liver disease Clinical feature
  • 相关文献

参考文献6

  • 1Benichou C. Criteria of drug-induced liver disorders. J Hepatol,1990,11:272
  • 2黄泳齐.肝病与全身性疾病[M].北京:中国医科大学中国协和医科大学联合出版社,1995.156,157.
  • 3姚光弼.第十一讲 药物性肝病[J].中华消化杂志,1999,19(5):339-342. 被引量:133
  • 4Ryan M, Desmond P. Liver toxicity. Could this be a drug reaction?Aust Faro Physician,2001,30(5) :427 - 431
  • 5王艳梅,程留芳.药物性肝病临床探讨[J].胃肠病学和肝病学杂志,2005,14(1):98-100. 被引量:17
  • 6Kane J A, Kane S P, Jain S. Hepatitis induced by traditional Chinese herbs: possible toxic components. Gut, 1995,36:146 - 147

二级参考文献11

  • 1Kaplowitz N. Drug-induced liver disease:implications for drug development and regulation. Drug Saf, 2001 ;24(7) :483-490.
  • 2Beinchou C. Griteria of Drng-induced liver disorders. Report of an international consensus meeting. J Hepatol, 1990,11 (2): 272-276.
  • 3Ryan M, Desmond P. Liver toxicity. Could this be a drug reaction? Aust Fam Physician,2001,30(5) :427-431.
  • 4Roy B, Chowdhury A, Kundu S, et al. Increased risk of antituberculosis druginduced hepatotoxicity in individuals with glutathiobne S-TRANSFERASE M1 NULL MUTATION.j Gastroenterol Hepatol,2001,16(9): 1033-1037.
  • 5Lewis JH, Schiff ER. Methatrexate-induced chronic liver injury: guidelines for detection and prevention. Am J Gastroenterol, 1988,88 (12): 1337-1345.
  • 6Huang YS, Chern HD, Su WJ, et al. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis. Hepatiology, 2002,35 ( 4 ): 883-889.
  • 7Escher M, Desmeules J, Giostra E, et al. Hepatitis associated with Kava, a herbal remedy for anxiety. BMJ,2001,322(7279): 139.
  • 8Speeg KV, Bay MK. Prevention and treatment of durg-induced liver disease. Gastroenterol Clin North Am, 1995,24(4): 1047-1064.
  • 9姚光弼.第十一讲 药物性肝病[J].中华消化杂志,1999,19(5):339-342. 被引量:133
  • 10陈世耀,蒋晓渠,刘天舒,王吉耀.药物性肝病的病因和临床表现[J].中华肝脏病杂志,2000,8(4):244-244. 被引量:88

共引文献146

同被引文献26

引证文献6

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部